Morgan Stanley Highlights | ACAD Message Board Posts

ACADIA Pharmaceuticals Inc.

  ACAD website

ACAD   /  Message Board  /  Read Message



Rec'd By
Authored By
Minimum Recs
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  15614 of 16894  at  9/11/2019 9:27:52 AM  by


Morgan Stanley Highlights

+ Acadia has initiated a new TV commercial this week.
+ Growth has been seen in physicians, prescribers, patients. (Market penetration is growing to mid to upper teens)
+ Doctors are treating PDP patients earlier than in the past.
+ Expansion of sales force for DRP "from existing position" is achievable. (The doctors writing scripts for PDP patients are the same ones who will be writing them for DRP patients)
+ Difference between Nuplazid and other antipsychotics in DRP: latter worsen cognition, exacerbate disease; Nuplazid doesn't.
+ Acadia will submit an sNDA in DRP next year (best guess is 1H).
+ Big disappointment in SSRI therapy in depression is sexual dysfunction. In Nuplazid phase 2 trial, improvement was seen in sexual function. CEO: what was seen in depression trial in efficacy is exactly what many physicians say they want in new therapies.
There was no slide presentation; just Steve and Serge fielding questions from the host. 

     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 29     Views: 611
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Msg # Subject Author Recs Date Posted
15615 Re: Morgan Stanley Highlights Biotech2050 2 9/11/2019 10:57:47 AM
15616 Re: Morgan Stanley Highlights-----Pimavanserin, the new Viagra gains_52 13 9/11/2019 12:37:55 PM
15619 Re: Morgan Stanley Highlights - Interesting implication longusa 5 9/11/2019 8:12:15 PM

About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 All rights reserved. User Agreement
Financial Market Data provided by